Search

everythinglearnresearchcommunity

for

Search:↓

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Stem cell therapy helps heal burn wounds, especially second-degree burns, by promoting blood vessel growth and reducing inflammation.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Current treatments for alopecia show no significant long-term benefits.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.